Fasting on GLP-1s: What Research Actually Shows About Semaglutide & Tirzepatide

Fasting on GLP-1s: What Research Actually Shows About Semaglutide & Tirzepatide Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring Fasting on GLP-1s: What Research Actually Shows About Semaglutide & Tirzepatide. ... Take a breath, settle in, and let's walk through this together — clearly, calmly, and based on what the evidence actually shows. ... We'll touch on GLP-1 Fasting, Tirzepatide Research, Semaglutide Weight Loss — especially as they apply to real people over forty. ... Intermittent fasting paired with GLP-1 receptor agonists like semaglutide or dual GLP-1/GIP agonists such as tirzepatide has become a hot topic in metabolic health. While these medications powerfully suppress appetite and improve insulin sensitivity, many wonder whether adding structured fasting enhances results or risks muscle loss and metabolic slowdown. Current research offers nuanced insights that move beyond the outdated CICO model, focusing instead on hormonal timing, inflammation reduction, and mitochondrial efficiency . ... First — how glp-1 and gip medications interact with fasting physiology. ... Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/fasting-on-glp-1s-like-semaglutide-or-tirzepatide-what-research-actually-shows-faq-what-the-research-says